These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10582480)

  • 41. Ovarian stimulation for IVF: mild approaches.
    Hamdine O; Broekmans FJ; Fauser BC
    Methods Mol Biol; 2014; 1154():305-28. PubMed ID: 24782016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clomiphene citrate or gonadotrophins for induction of ovulation?
    Out HJ; Coelingh Bennink HJ
    Hum Reprod; 1998 Sep; 13(9):2358-61. PubMed ID: 9806246
    [No Abstract]   [Full Text] [Related]  

  • 43. Strategies to prevent multiple pregnancies in assisted conception programmes.
    Child TJ; Barlow DH
    Baillieres Clin Obstet Gynaecol; 1998 Mar; 12(1):131-46. PubMed ID: 9930294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovulation induction in gonadotrophin-resistant women.
    Homburg R
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):349-61. PubMed ID: 8358895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cancer, fertility preservation and gonadotropins].
    Grynberg M; Even M; Berwanger da Silva AL; Gallot V; Toledano M; Frydman R; Fanchin R
    J Gynecol Obstet Biol Reprod (Paris); 2012 Oct; 41(6):512-8. PubMed ID: 22633037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No relationship between the type of pituitary suppression for IVF and chromosomal abnormality rates of blastomeres: an observational study.
    Kyrou D; Verpoest W; Staessen C; De Vos A; Haentjens P; Liebaers I; Devroey P
    Fertil Steril; 2011 Feb; 95(2):563-7. PubMed ID: 20576261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [20 years in vitro fertilization: what follows?].
    De Geyter C
    Ther Umsch; 1999 May; 56(5):240-5. PubMed ID: 10409897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are recombinant gonadotrophins safer, purer and more effective than urinary gonadotrophins?
    Casper RF
    Reprod Biomed Online; 2005 Nov; 11(5):539-40. PubMed ID: 16409695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled ovarian stimulation for in-vitro fertilization.
    Howie R; Kay V
    Br J Hosp Med (Lond); 2018 Apr; 79(4):194-199. PubMed ID: 29620984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ovarian stimulation protocol and the outcome of in vitro fertilization are not related to the ability of follicular fluid to induce sperm acrosome reaction.
    Ramirez JP; Castilla JA; Molina J; Gonzalvo MC; Gil T; Vergara F; Herruzo A
    Andrologia; 1994; 26(5):303-4. PubMed ID: 7825746
    [No Abstract]   [Full Text] [Related]  

  • 51. A prospective randomized study to assess the clinical efficacy of gonadotrophins administered subcutaneously and intramuscularly.
    Engmann L; Shaker A; White E; Bekir JS; Jacobs HS; Tan SL
    Hum Reprod; 1998 Apr; 13(4):836-40. PubMed ID: 9619533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prednisolone supplementation to Clomid and/or gonadotrophin stimulation for in-vitro fertilization--a prospective randomized trial.
    Kemeter P; Feichtinger W
    Hum Reprod; 1986 Nov; 1(7):441-4. PubMed ID: 2952668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant gonadotrophins in reproductive medicine: gold standard for ovarian stimulation therapy in the 21st century.
    Ludwig M; Keck C
    Reprod Biomed Online; 2005 Nov; 11(5):535-6. PubMed ID: 16409693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New concepts in superovulation strategies for assisted conception treatments.
    Salha O; Balen AH
    Curr Opin Obstet Gynecol; 2000 Jun; 12(3):201-6. PubMed ID: 10873121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation.
    Sighinolfi G; Sunkara SK; La Marca A
    Reprod Biomed Online; 2018 Oct; 37(4):489-497. PubMed ID: 30170909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new concept of cotreatment with human growth hormone and menotropins in ovulation induction protocols.
    Orvieto R; Homburg R; Farhi J; Bar-Hava I; Ben-Rafael Z
    Med Hypotheses; 1997 Nov; 49(5):413-5. PubMed ID: 9421807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze.
    Filicori M; Cognigni GE; Pocognoli P; Ciampaglia W
    Fertil Steril; 2003 Nov; 80(5):1114-6. PubMed ID: 14607558
    [No Abstract]   [Full Text] [Related]  

  • 58. Kallmann syndrome in females: gonadotropin versus GnRH to induce fertility.
    Imai A; Tamaya T
    J Med; 1996; 27(3-4):237-40. PubMed ID: 8982973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The combined suppression/stimulation therapy in IVF-ET programmes: expectations and facts.
    Insler V; Potashnik G; Lunenfeld E; Meizner I; Levy J
    Hum Reprod; 1989 Nov; 4(8 Suppl):47-51. PubMed ID: 2693489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drugs used in in vitro fertilisation procedures.
    Messinis IE
    Drugs; 1989 Jul; 38(1):148-59. PubMed ID: 2504576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.